Jason Rhodes is a partner at Atlas Venture who creates and builds novel therapeutics companies. He has held leadership roles at Alnylam Pharmaceuticals and Epizyme, and was a founder and partner at Fidelity Biosciences.
What Jason can write
Career
- K36 Therapeutics · chairman
- KaryoVerse · chairman
- AAVantgarde Bio · board member
- Mithril · board member
- Weaver · board member
- Epizyme
- Alnylam Pharmaceuticals
- Atlas Venture · PartnerNow
Companies founded
Investments named in public bios
Focus
Education
Also at Atlas Venture
Partners like Jason
At firms with a similar stage, sector and check size.
Alert me when Atlas Venture is active
One email when Jason's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Jason Rhodes?
Jason Rhodes is a partner at Atlas Venture who creates and builds novel therapeutics companies. He has held leadership roles at Alnylam Pharmaceuticals and Epizyme, and was a founder and partner at Fidelity Biosciences.
How much does Jason Rhodes invest?
Atlas Venture has not reported a check size. It invests at seed, series a.
How do I pitch Jason Rhodes?
A warm intro from a founder Atlas Venture backed works best.
What did Jason Rhodes do before Atlas Venture?
chairman at K36 Therapeutics; chairman at KaryoVerse; board member at AAVantgarde Bio; board member at Mithril; board member at Weaver; Epizyme; Alnylam Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.